REG - MyCelx Tech. Corp. MyCelx Tech. Corp.. - Director/PDMR Shareholding

Mycelx TechnologiesAnnouncement

09/11/2021 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211109:nRSI8508Ra&default-theme=true

RNS Number : 8508R  MyCelx Technologies Corporation  09 November 2021

9 November 2021

 

Mycelx Technologies Corporation

("Mycelx" or the "Company" (AIM: MYX)

 

 

Dealing by Director

 

The Company announces that it was notified on 9 November 2021 by Connie Mixon,
Chief Executive Officer and a Director of the Company, that on 9 November 2021
she purchased 24,000 Common Shares at a price of £0.60 per Common Share.
Following this transaction, she continues to be interested in 2,514,469 Common
Shares representing 12.93 per cent of the present issued capital of the
Company and in 413,017 options over the Company's Common Shares.

 

The aggregate number of Common Shares held by Ms. Mixon also includes (a)
150,000 shares held by limited liability companies controlled by Ms. Mixon;
(b) 202,646 shares held by or on behalf of Ms. Mixon's children; and (c)
10,000 shares which are held by the estate of her late husband Mark Mixon as a
custodian.

 

 

For further information please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                     Tel: +1 888 306 6843

 Kim Slayton, CFO

 Canaccord Genuity, Nominated Adviser

 Henry Fitzgerald-O'Connor             Tel: + 44 20 7523 8000

 Georgina McCooke

 Celicourt

 Mark Antelme                          Tel: +44 20 8434 2754

 Jimmy Lea

 

Notification of transactions of persons discharging managerial responsibility
or connected persons

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Connie Mixon

 2    Reason for the notification

 a)   Position/status                                              Director

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Mycelx Technologies Corporation

 b)   LEI                                                          213800UJZINIK2VD1G48

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument

                                                                   Common shares of US$0.025

      Identification code

                                                                   USU624551078

 b)   Nature of the transaction                                    Purchase of Common Shares

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   £0.60     24,000

 

 d)   Aggregated information

      - Aggregated volume                                          n/a

      - Price                                                      n/a

 e)   Date of the transaction                                      9/11/2021

 f)   Place of the transaction                                     London Stock Exchange

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

9/11/2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFVRLALAIIL